M&A Update – April 17

– RXDX to be acquired by MRK for $200.00 cash per share, 75.3% premium, $10.8 billion
– STSA to be acquired by Shin Nippon Biomedical for $0.91 cash per share + CVR, 37.9% premium, $30.2 million
– HZNP / AMGN announced Irish High Court set May 22 hearing for merger
– HAI.to board of directors rejected $4.75 unsolicited proposal from Evertz Technologies
– TA / BP / ARKO announced it can potentially provide even more value than $92.00 per share in cash to TravelCenters’ stockholders
– MNTV / Symphony Technology Group filed PREM14a, filed HS Mar 24, closing Q2 or Q3
– TGNA / Standard General makes additional unprecedented commitments to TNG-NABET
– ATVI / MSFT cleared South Africa
– HCG.to / Smith Financial cleared Competition Canada
– SGEN / PFE filed PREM14a, filed EC Apr 5, closing late 2023 or early 2024
– INDT / Centerbridge Partners / GIC filed DEFM14a, vote May 17, filed EC Apr 13, closing summer 2023
– MAXR / Advent International received majority of the regulatory consents required, closing late Apr / early May
– LMST / PEBO received all necessary regulatory approvals
– NUVA / GMED announced ISS recommends shareholders vote For
– HZNP / AMGN set May 24 court hearing
– TCFC / SHBI filed S-4, closing July 1